Status:
UNKNOWN
Ventilator Associated Pneumonia in Taper Guard Versus Normal Tube in ICU Patients
Lead Sponsor:
University of Malaya
Conditions:
Ventilator Associated Pneumonia
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
Ventilator associated pneumonia ( VAP) adds burden to the care of the intensive care patients as they may cause the death of the patient or prolong the intensive care stay or complicate the illness in...
Detailed Description
Methodology This will be a prospective randomized trial with 2 treatment groups with 100 patients in each arm. The control group ( Group C) will be intubated with our conventional endotracheal tubes a...
Eligibility Criteria
Inclusion
- All adult patients above 18 years old admitted into the Intensive Care unit and who is to be intubated and likely to receive more than 72 hours of ventilation would be admitted into the trial
Exclusion
- presence of cavitary lung disease based on chest x-ray findings,
- primary lung cancer or another metastatic malignancy to the lungs, or known or suspected viral or fungal etiology,
- pneumocystis carinii pneumonia,
- legionella OR Mycoplasma pneumonia or active tuberculosis.
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01501227
Start Date
February 1 2012
End Date
December 1 2013
Last Update
December 29 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Malaya Medical Centre
Kuala Lumpur, Malaysia, 50603